• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对阿尔茨海默病中的神经炎症:从机制到临床应用

Targeting neuroinflammation in Alzheimer's disease: from mechanisms to clinical applications.

作者信息

Si Zi-Zhen, Zou Chen-Jun, Mei Xi, Li Xiao-Fang, Luo Hu, Shen Yao, Hu Jun, Li Xing-Xing, Wu Lun, Liu Yu

机构信息

Pharmacy Department, The Affiliated Hospital of Medical School; Department of Physiology and Pharmacology, School of Medicine, Ningbo University, Ningbo, Zhejiang Province, China.

Department of Geriatric Psychiatry, Ningbo Kangning Hospital, Ningbo, Zhejiang Province, China.

出版信息

Neural Regen Res. 2023 Apr;18(4):708-715. doi: 10.4103/1673-5374.353484.

DOI:10.4103/1673-5374.353484
PMID:36204826
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9700083/
Abstract

Alzheimer's disease is characterized by sustained neuroinflammation leading to memory loss and cognitive decline. The past decade has witnessed tremendous efforts in Alzheimer's disease research; however, no effective treatment is available to prevent disease progression. An increasing body of evidence suggests that neuroinflammation plays an important role in Alzheimer's disease pathogenesis, alongside the classical pathological hallmarks such as misfolded and aggregated proteins (e.g., amyloid-beta and tau). Firstly, this review summarized the clinical and pathological characteristics of Alzheimer's disease. Secondly, we outlined key aspects of glial cell-associated inflammation in Alzheimer's disease pathogenesis and provided the latest evidence on the roles of microglia and astrocytes in Alzheimer's disease pathology. Then, we revealed the double-edged nature of inflammatory cytokines and inflammasomes in Alzheimer's disease. In addition, the potential therapeutic roles of innate immunity and neuroinflammation for Alzheimer's disease were also discussed through these mechanisms. In the final section, the remaining key problems according to the current research status were discussed.

摘要

阿尔茨海默病的特征是持续的神经炎症,导致记忆丧失和认知能力下降。在过去十年里,阿尔茨海默病的研究投入了巨大努力;然而,目前尚无有效的治疗方法来阻止疾病进展。越来越多的证据表明,神经炎症在阿尔茨海默病发病机制中起着重要作用,同时还伴随着诸如错误折叠和聚集蛋白(如β-淀粉样蛋白和tau蛋白)等经典病理特征。首先,本综述总结了阿尔茨海默病的临床和病理特征。其次,我们概述了阿尔茨海默病发病机制中与神经胶质细胞相关的炎症的关键方面,并提供了关于小胶质细胞和星形胶质细胞在阿尔茨海默病病理学中作用的最新证据。然后,我们揭示了炎症细胞因子和炎性小体在阿尔茨海默病中的双刃剑性质。此外,还通过这些机制讨论了固有免疫和神经炎症对阿尔茨海默病的潜在治疗作用。在最后一部分,根据当前的研究现状讨论了剩余的关键问题。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87e2/9700083/8b84ef7bea47/NRR-18-708-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87e2/9700083/048b24acd1c4/NRR-18-708-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87e2/9700083/59ed9c848b09/NRR-18-708-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87e2/9700083/2a3496d2aef3/NRR-18-708-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87e2/9700083/8b84ef7bea47/NRR-18-708-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87e2/9700083/048b24acd1c4/NRR-18-708-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87e2/9700083/59ed9c848b09/NRR-18-708-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87e2/9700083/2a3496d2aef3/NRR-18-708-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87e2/9700083/8b84ef7bea47/NRR-18-708-g004.jpg

相似文献

1
Targeting neuroinflammation in Alzheimer's disease: from mechanisms to clinical applications.针对阿尔茨海默病中的神经炎症:从机制到临床应用
Neural Regen Res. 2023 Apr;18(4):708-715. doi: 10.4103/1673-5374.353484.
2
Emerging Roles of Cells and Molecules of Innate Immunity in Alzheimer's Disease.固有免疫细胞和分子在阿尔茨海默病中的新作用。
Int J Mol Sci. 2023 Jul 25;24(15):11922. doi: 10.3390/ijms241511922.
3
The role of natural flavonoids on neuroinflammation as a therapeutic target for Alzheimer's disease: a narrative review.天然黄酮类化合物在神经炎症中的作用作为阿尔茨海默病的治疗靶点:一项叙述性综述。
Neural Regen Res. 2023 Dec;18(12):2582-2591. doi: 10.4103/1673-5374.373680.
4
Sirtuins as Potential Therapeutic Targets for Mitigating Neuroinflammation Associated With Alzheimer's Disease.沉默调节蛋白作为减轻与阿尔茨海默病相关神经炎症的潜在治疗靶点。
Front Cell Neurosci. 2021 Sep 22;15:746631. doi: 10.3389/fncel.2021.746631. eCollection 2021.
5
Innate Immunity and Cell Death in Alzheimer's Disease.阿尔茨海默病中的先天免疫和细胞死亡。
ASN Neuro. 2021 Jan-Dec;13:17590914211051908. doi: 10.1177/17590914211051908.
6
Potential therapeutic roles of retinoids for prevention of neuroinflammation and neurodegeneration in Alzheimer's disease.维甲酸在预防阿尔茨海默病神经炎症和神经退行性变中的潜在治疗作用。
Neural Regen Res. 2019 Nov;14(11):1880-1892. doi: 10.4103/1673-5374.259604.
7
TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease.TLR4 与 NLRP3 炎性小体及补体信号通路在阿尔茨海默病中的相互作用。
Front Immunol. 2020 Apr 23;11:724. doi: 10.3389/fimmu.2020.00724. eCollection 2020.
8
Tau and neuroinflammation: What impact for Alzheimer's Disease and Tauopathies?tau 与神经炎症:对阿尔茨海默病和 tau 病有何影响?
Biomed J. 2018 Feb;41(1):21-33. doi: 10.1016/j.bj.2018.01.003. Epub 2018 Mar 20.
9
Astrocytic and microglial cells as the modulators of neuroinflammation in Alzheimer's disease.星形胶质细胞和小胶质细胞作为阿尔茨海默病神经炎症的调节剂。
J Neuroinflammation. 2022 Aug 17;19(1):206. doi: 10.1186/s12974-022-02565-0.
10
Microglia and microglial-based receptors in the pathogenesis and treatment of Alzheimer's disease.小胶质细胞及其相关受体在阿尔茨海默病发病机制和治疗中的作用。
Int Immunopharmacol. 2022 Sep;110:109070. doi: 10.1016/j.intimp.2022.109070. Epub 2022 Jul 21.

引用本文的文献

1
Identification of pathogenic cell types and shared genetic loci and genes for Alzheimer's disease and inflammatory bowel disease.阿尔茨海默病和炎症性肠病的致病细胞类型以及共享遗传位点和基因的鉴定。
Brief Funct Genomics. 2025 Jan 15;24. doi: 10.1093/bfgp/elaf013.
2
Alamandine Rescues Cognitive Impairment and Ameliorates Alzheimer's Disease-Like Neuropathology in APP/PS1 Mice.alamandine可挽救APP/PS1小鼠的认知障碍并改善类似阿尔茨海默病的神经病理学变化。
Neurochem Res. 2025 Aug 25;50(5):277. doi: 10.1007/s11064-025-04531-7.
3
The role of peripheral innate immune cells in Alzheimer's disease progression.

本文引用的文献

1
Crry silencing alleviates Alzheimer's disease injury by regulating neuroinflammatory cytokines and the complement system.Crry基因沉默通过调节神经炎症细胞因子和补体系统减轻阿尔茨海默病损伤。
Neural Regen Res. 2022 Aug;17(8):1841-1849. doi: 10.4103/1673-5374.332160.
2
Reactive astrocytes: The nexus of pathological and clinical hallmarks of Alzheimer's disease.反应性星形胶质细胞:阿尔茨海默病病理和临床特征的交汇点。
Ageing Res Rev. 2021 Jul;68:101335. doi: 10.1016/j.arr.2021.101335. Epub 2021 Mar 31.
3
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
外周固有免疫细胞在阿尔茨海默病进展中的作用。
Front Immunol. 2025 Jul 16;16:1616939. doi: 10.3389/fimmu.2025.1616939. eCollection 2025.
4
Mir-199a-3p aggravates neuroinflammation in an Alzheimer's disease transgenic mouse model by promoting M1-polarization microgliaMir-199a-3p M1.Mir-199a-3p通过促进M1极化小胶质细胞加重阿尔茨海默病转基因小鼠模型中的神经炎症。Mir-199a-3p M1。 (注:原文最后“Mir-199a-3p M1”表述不太清晰准确,可能影响理解,但按要求直接翻译)
BMC Neurosci. 2025 Jul 24;26(1):45. doi: 10.1186/s12868-025-00965-5.
5
The neuroprotective effects of hesperidin and diosmin in neurological disorders via targeting various signaling pathways.橙皮苷和地奥司明通过靶向多种信号通路在神经疾病中的神经保护作用。
Iran J Basic Med Sci. 2025;28(7):825-834. doi: 10.22038/ijbms.2025.81908.17719.
6
The neurobiological foundation of effective repetitive transcranial magnetic brain stimulation in Alzheimer's disease.阿尔茨海默病中有效重复经颅磁刺激的神经生物学基础。
Alzheimers Dement. 2025 Jun;21(6):e70337. doi: 10.1002/alz.70337.
7
André Rhizome Extract Alleviates Scopolamine-Induced Cognitive Impairment and Neuroinflammation in Rats.安德烈生姜提取物减轻东莨菪碱诱导的大鼠认知障碍和神经炎症。
Adv Pharmacol Pharm Sci. 2025 May 26;2025:7334303. doi: 10.1155/adpp/7334303. eCollection 2025.
8
Alzheimer's disease and the immune system: A comprehensive overview with a focus on B cells, humoral immunity, and immunotherapy.阿尔茨海默病与免疫系统:聚焦B细胞、体液免疫和免疫疗法的全面综述
J Alzheimers Dis Rep. 2025 Apr 27;9:25424823251329188. doi: 10.1177/25424823251329188. eCollection 2025 Jan-Dec.
9
Mapping the scientific research on exercise therapy for Alzheimer's disease: a scientometric study of hotspots and emerging trends.绘制关于阿尔茨海默病运动疗法的科学研究图谱:热点与新趋势的科学计量学研究
Front Aging Neurosci. 2025 Apr 3;17:1536515. doi: 10.3389/fnagi.2025.1536515. eCollection 2025.
10
Harnessing human iPSC-microglia for CNS-wide delivery of disease-modifying proteins.利用人诱导多能干细胞来源的小胶质细胞在中枢神经系统中广泛递送疾病修饰蛋白。
Cell Stem Cell. 2025 Jun 5;32(6):914-934.e8. doi: 10.1016/j.stem.2025.03.009. Epub 2025 Apr 14.
阿尔茨海默病中的神经炎症和小胶质细胞激活:我们的路在何方?
Nat Rev Neurol. 2021 Mar;17(3):157-172. doi: 10.1038/s41582-020-00435-y. Epub 2020 Dec 14.
4
Patient-centered connectivity-based prediction of tau pathology spread in Alzheimer's disease.基于患者中心的连接性预测阿尔茨海默病tau 病理扩散。
Sci Adv. 2020 Nov 27;6(48). doi: 10.1126/sciadv.abd1327. Print 2020 Nov.
5
What Does the APP Family Do in the Brain?APP 家族在大脑中做什么?
Neuron. 2020 Nov 25;108(4):583-585. doi: 10.1016/j.neuron.2020.11.003.
6
Alzheimer's disease beyond amyloid: strategies for future therapeutic interventions.阿尔茨海默病的淀粉样蛋白之外:未来治疗干预的策略。
BMJ. 2020 Oct 9;371:m3684. doi: 10.1136/bmj.m3684.
7
The Neuroprotective and Neurodegeneration Effects of Heme Oxygenase-1 in Alzheimer's Disease.血红素加氧酶-1 在阿尔茨海默病中的神经保护和神经退行性作用。
J Alzheimers Dis. 2020;78(4):1259-1272. doi: 10.3233/JAD-200720.
8
Translating genetic risk of Alzheimer's disease into mechanistic insight and drug targets.将阿尔茨海默病的遗传风险转化为机制见解和药物靶点。
Science. 2020 Oct 2;370(6512):61-66. doi: 10.1126/science.abb8575.
9
The search for Alzheimer disease therapeutics - same targets, better trials?阿尔茨海默病治疗方法的探索——相同靶点,更好的试验?
Nat Rev Neurol. 2020 Nov;16(11):597-598. doi: 10.1038/s41582-020-00414-3.
10
Prion biology: implications for Alzheimer's disease therapeutics.朊病毒生物学:对阿尔茨海默病治疗的启示。
Lancet Neurol. 2020 Oct;19(10):802-803. doi: 10.1016/S1474-4422(20)30274-X. Epub 2020 Sep 16.